“The Mitigating Role of Transresveratrol Against Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients via Modulating Mitochondrial Gene Expression: A Randomized Controlled Trial”. 2024. Journal of Carcinogenesis 23 (1): 751-70. https://doi.org/10.64149/J.Carcinog.23.1.751-770.